SHL to present & exhibit at 10th Annual BIO Asia International Conference
pharmafile | January 9, 2013 | News story | Manufacturing and Production | auto injector, autoinjector, shl events
SHL will be presenting and exhibiting at the upcoming 10th Annual BIO Asia International Conference from January 29-30th in Tokyo, Japan. BIO Asia is the longest running Asian partnering event designed specifically to facilitate collaboration between biopharmaceutical companies and suppliers. As a global leader in auto injector and pen injector design, development and manufacturing, SHL hopes to better understand current trends and demands of the biopharmaceutical industry in Asia.
Marketing Director Steven Kaufman who will be speaking at this event commented, “I’ve been looking forward to the BIO Asia International Conference since attending one of the BIO events in China last year. SHL is pleased to have the opportunity to not only introduce our company and products at this conference, but also to exhibit and demonstrate our injection devices to help other attendees better understand the benefits of auto injectors and pen injectors.”
The topics and structure of this conference are specifically geared towards Asian based companies who continue to expand their reach and influence. Commenting on this topic, Steven continued, “Demand for drug delivery devices will continue to grow and Japan is clearing an important market. Japanese-based biopharma companies are investing more resources in developing new devices and are expanding their influence internationally with mergers and acquisitions. With the majority of SHL’s device production being in Taiwan, it makes sense that we focus more on developing new partnerships in Asia.”
For biopharmaceutical companies that are interested in attending this conference and meeting with SHL, please visit www.bio.org/asia and once ready, send us a request for a one-on-one meeting.
About SHL
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 2,000 staff globally, with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.
SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of three distinct group companies:
SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
SHL Pharma
Provides final assembly, labeling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries
For additional information visit www.shl-group.com or contact us at info@shl-group.com
SHL Media Contact
Steven R. Kaufman
Marketing Director
pr@shl-group.com
Related Content
Novartis secures US rights to Adamis’ epinephrine auto injector
Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine …
FDA unveils guidelines to help generic medical device versions reach the market
The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of …
SHL brings innovation to Pharmapack Europe 2017
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on …
